Trial intelligence / Profile preview

Target-controlled Infusion With Propofol in the Emergency Department

NCT03783494Phase 4Completed

Sponsor
Centre Hospitalier Universitaire de Nice
Start
May 2019
Primary completion
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of propofol injection (veterinary) in joint dislocation and limb fracture, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Propofol brain concentration. Started May 2019; status: completed.

02

Drugs

propofol injection (veterinary)
03

Conditions

joint dislocationlimb fracture

Beyond the preview

Go deeper on NCT03783494.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03783494.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call